P-030: crizanlizumab reduces endothelial adhesion of red blood cells from scd patients in standardized microfluidic platform: in vitro technology assessment

FEDERICI C.,KUCUKAL E.,KOCEVAR R., GILKEY L., SERTEL S., MONCHAMP K., WOLFE A.,NAYAK L., BRUEDERLE A., ZAK J.,GURKAN U.

HemaSphere（2022）

引用 0|浏览1

暂无评分

关键词

crizanlizumab reduces endothelial adhesion,standardized microfluidic platform,reduces blood cells,scd patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要